Michael Untch
Arzt,
Gynäkologe
Hat mitgewirkt an:
-
Immunzytochemischer Nachweis von Tumorzellen im Knochenmark mittels monoklonaler Antikörper bei Mammakarzinompatientinnen zum Zeitpunkt der Primärtherapie
-
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE
-
Early modulation of circulating MicroRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
-
ABC3 Consensus Commented from the Perspective of the German Guidelines : Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015